Group One Trading
DPLO

Group One Trading’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Group One Trading’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-349,500
Closed -$1.4M – 6096
2019
Q4 		$1.4M Buy
+349,500
New +$1.64M 0.01% 1585
2019
Q3 		– Sell
-700
Closed -$4K – 5814
2019
Q2 		$4K Sell
700
-1,900
-73% -$10.1K ﹤0.01% 4675
2019
Q1 		$15K Buy
+2,600
New +$26.8K ﹤0.01% 4144
2018
Q2 		– Sell
-100
Closed -$2K – 5695
2018
Q1 		$2K Sell
100
-300
-75% -$7K ﹤0.01% 4668
2017
Q4 		$8K Sell
400
-1,100
-73% -$21.6K ﹤0.01% 4458
2017
Q3 		$31K Buy
1,500
+100
+7% +$1.69K ﹤0.01% 3870
2017
Q2 		$21K Buy
+1,400
New +$23.3K ﹤0.01% 3939
2016
Q3 		– Sell
-21,800
Closed -$763K – 5107
2016
Q2 		$763K Buy
21,800
+5,100
+31% +$160K 0.01% 1422
2016
Q1 		$458K Buy
16,700
+3,400
+26% +$100K 0.01% 1753
2015
Q4 		$455K Sell
13,300
-15,700
-54% -$490K 0.01% 1892
2015
Q3 		$833K Buy
29,000
+18,600
+179% +$795K 0.01% 1380
2015
Q2 		$465K Buy
10,400
+300
+3% +$11.3K 0.01% 1839
2015
Q1 		$349K Buy
+10,100
New +$275K 0.01% 1909

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's DPLO Position: Q1 2020 in Review

Group One Trading sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 162,227 shares — an estimated $649K sold.

Group One Trading first reported a position in DPLO in Q4 2015 and held it in 15 quarters. The position peaked at $649K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Group One Trading reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 162,227 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $649K.
  • Group One Trading first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 15 quarters.
  • Group One Trading's DIPLOMAT PHARMACY, INC. position peaked at $649K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.